Literature DB >> 32186209

The cancer hypothesis of pulmonary arterial hypertension: the next ten years.

David Condon1,2,3, Stuti Agarwal1,2,3, Ananya Chakraborty1,2,3, Vinicio A de Jesus Perez1,2,3.   

Abstract

Keywords:  angiogenesis; cancer; pulmonary hypertension

Mesh：

Year:  2020        PMID： 32186209      PMCID： PMC7642842          DOI： 10.1152/ajplung.00057.2020

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN： 1040-0605            Impact factor:   5.464


× No keyword cloud information.
  10 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.

Authors:  Sébastien Bonnet; Steeve Provencher; Christophe Guignabert; Frédéric Perros; Olivier Boucherat; Ralph Theo Schermuly; Paul M Hassoun; Marlene Rabinovitch; Mark R Nicolls; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2017-03-01       Impact factor: 21.405

Review 3.  A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

Authors:  Wolfgang M Kuebler; Mark R Nicolls; Andrea Olschewski; Kohtaro Abe; Marlene Rabinovitch; Duncan Stewart; Stephen Y Chan; Nicholas W Morrell; Stephen L Archer; Edda Spiekerkoetter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-07       Impact factor: 5.464

Review 4.  Emerging therapeutics in pulmonary hypertension.

Authors:  Matthew K Hensley; Andrea Levine; Mark T Gladwin; Yen-Chun Lai
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-01       Impact factor: 5.464

5.  PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics.

Authors:  Anna R Hemnes; Gerald J Beck; John H Newman; Aiden Abidov; Micheala A Aldred; John Barnard; Erika Berman Rosenzweig; Barry A Borlaug; Wendy K Chung; Suzy A A Comhair; Serpil C Erzurum; Robert P Frantz; Michael P Gray; Gabriele Grunig; Paul M Hassoun; Nicholas S Hill; Evelyn M Horn; Bo Hu; Jason K Lempel; Bradley A Maron; Stephen C Mathai; Mitchell A Olman; Franz P Rischard; David M Systrom; W H Wilson Tang; Aaron B Waxman; Lei Xiao; Jason X-J Yuan; Jane A Leopold
Journal:  Circ Res       Date:  2017-10-27       Impact factor: 17.367

6.  Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.

Authors:  Evangelos D Michelakis; Vikram Gurtu; Linda Webster; Gareth Barnes; Geoffrey Watson; Luke Howard; John Cupitt; Ian Paterson; Richard B Thompson; Kelvin Chow; Declan P O'Regan; Lan Zhao; John Wharton; David G Kiely; Adam Kinnaird; Aristeidis E Boukouris; Chris White; Jayan Nagendran; Darren H Freed; Stephen J Wort; J Simon R Gibbs; Martin R Wilkins
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

7.  Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.

Authors:  Andrew J Sweatt; Haley K Hedlin; Vidhya Balasubramanian; Andrew Hsi; Lisa K Blum; William H Robinson; Francois Haddad; Peter M Hickey; Robin Condliffe; Allan Lawrie; Mark R Nicolls; Marlene Rabinovitch; Purvesh Khatri; Roham T Zamanian
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 9.  The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis-ten years later.

Authors:  Carlyne D Cool; Wolfgang M Kuebler; Harm Jan Bogaard; Edda Spiekerkoetter; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-05       Impact factor: 6.011

Review 10.  Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again.

Authors:  Kurt W Prins; Thenappan Thenappan; E Kenneth Weir; Rajat Kalra; Marc Pritzker; Stephen L Archer
Journal:  J Am Heart Assoc       Date:  2019-01-08       Impact factor: 5.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.